The sale of a local health care provider and its integration with a major health care entity is expected to be finalized next month.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Received FDA authorization and recorded first commercial sales of ARC-EX SystemSecured strategic investment from Ottobock and extended cash ...

Inspīr Embassy Row is now open and welcoming residents. The new luxury senior living residence, proudly announces its comprehensive Integrated Care Model (ICM), establishing new standards in ...

This ongoing industry growth stems from the broad spectrum of use cases that have arisen for XT technology for clinicians and ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Advanced Medical--which specializes in tissue-healing technologies--said in response that it hadn't received any proposal from Montagu. Montagu has until April 24 to either make a formal offer to buy ...

Medical Solutions is excited to announce that Aureus Medical Group is officially transitioning to the Medical Solutions brand ...

A chance discovery led a team of scientists from Rice University, University of Cambridge and Stanford University to ...

Logo New partnership expands clinical trials in Denver for people with GI conditions. The decision helps people gain access to GI therapies ...

28th Mar 2025 3:05 pm GNW Form 8.3 - AXA INVESTMENT MANAGERS: Advanced Medical Solutions Group plc 28th Mar 2025 3:00 pm RNS Form 8.3 - Advanced Medical Solutions Group PLC 28th Mar 2025 2:40 pm ...

A British IT service company must pay a 3.07 million pound fine for a 2022 ransomware hack that exposed medical records of ...